Agrata Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 01-01-2025
- Paid Up Capital ₹ 1.00 Cr
as on 01-01-2025
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 2.00 Cr
as on 01-01-2025
- Revenue %
(FY 2020)
- Profit 7.94%
(FY 2020)
- Ebitda -379.72%
(FY 2020)
- Net Worth -6.50%
(FY 2020)
- Total Assets -22.64%
(FY 2020)
About Agrata Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kanthan Nagarajan, Maharajapillai Thirumalai, and Jayaraman Venkatanarasimhan serve as directors at the Company.
- CIN/LLPIN
U74999TN2009PLC071298
- Company No.
071298
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2009
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Agrata Biotech Limited offer?
Agrata Biotech Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Anti Infective Drugs & Medicines, Anti Infective Agent, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Cardiac Drugs, Sexual Wellness Products, Fertility Enhancer, Steroid.
Who are the key members and board of directors at Agrata Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanthan Nagarajan  | Director | 12-Mar-2021 | Current |
| Maharajapillai Thirumalai | Director | 12-Mar-2021 | Current |
| Jayaraman Venkatanarasimhan | Director | 12-Mar-2021 | Current |
Financial Performance of Agrata Biotech.
Agrata Biotech Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.94% increase in profit. The company's net worth dipped by a decrease of 6.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrata Biotech?
In 2020, Agrata Biotech had a promoter holding of 65.50% and a public holding of 34.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Verna Softech LimitedActive 25 years 3 monthsKanthan Nagarajan, Maharajapillai Thirumalai and 1 more are mutual person
Charges (Loans)
₹0
₹2.00 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 1.20 Cr
- Indian Bank : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2014 | Yes Bank Limited | ₹1.20 Cr | Satisfied |
| 13 Oct 2012 | Indian Bank | ₹8.00 M | Satisfied |
How Many Employees Work at Agrata Biotech?
Unlock and access historical data on people associated with Agrata Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrata Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrata Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
